Novacyt Group

Wishing our customers, partners and colleagues a Happy Diwali! #Diwali2024

NCYT - Directorate change Dr Ian Gilham appointed as Non-Executive Director Novacyt announces the appointment of Dr Ian Gilham as a Non-Executive Director with immediate effect.  Lyn Rees, CEO of Novacyt, commented: “It is a pleasure to welcome Ian to the Board of Novacyt. Ian has worked with a number of successful AIM-listed life sciences companies and we look forward to utilising his expertise as we further optimise and strengthen the Novacyt Group.” Click to read the full press release: https://lnkd.in/exwguEiF

Press Release - 26.09.24 Directorate change Dr John Brown CBE appointed as Chairman Dr John Brown, Incoming Chairman said: “I am delighted to be appointed Chairman of Novacyt.  The Group has a strong and diverse portfolio of differentiated molecular diagnostic products, established sales channels and a world-class team of experts.  I look forward to continuing to work with Lyn and the rest of the Board as we drive the business through the next stage of development.”

Press Release - 26.09.24 Novacyt Group: Dr John Brown CBE appointed as Chairman Lyn Rees, CEO of Novacyt, commented: “It is a pleasure to have John stepping into the role of Chairman at Novacyt. John has a proven track record of successfully building life sciences companies and his wealth of knowledge in capital markets and the life sciences sector will be important as we look to execute the strategic plan of the combined business”.

We are exhibiting at the The National Institutes of Health Research Festival today in Bethesda! Come and meet the team to learn about our 3-in-1 Ranger® Technology instruments for DNA Size Selection, Fragment Length Analysis and Library Quantification. We have a LightBench® instrument we'd love to show you! The LightBench® is PacBio Compatible - enabling PacBio customers to optimise size selection for long-read sequencing libraries. The LightBench® offers precise and accurate size selection of PacBio SMRTbell libraries increasing HiFi sequencing yields. #NIH #NIHFall2024 #Research #PacBio #Partner #Sequencing #SizeSelection Cindy Baptiste Dave Cox MOHAMADOU SENE

Just Launched: Our new Novacyt Group website is now live! The new site better reflects the expanded Group, representing the three companies within the Novacyt Group www.novacyt.com #NewWebsite #IR #Careers

📢 Novacyt Group S.A. - Launch of new website 💻 The new site (www.novacyt.com) better reflects the expanded Group following the acquisition of Yourgene Health, with all information required by AIM Rule 26 available here: www.novacyt.com/investors.

Rapid Aneuploidy Analysis - Benefits of the Yourgene QST*R Range ✔️CE-IVD marked - High quality, fully validated and regulated product requires minimal validation to fit into your workflow ✔️Rapid Workflow - Fast workflow enables rapid delivery of results, enabling laboratories to maintain best service TAT - Patients receive results quickly, permitting timely downstream management ✔️Single Tube Assay - Simple to use; just add DNA - Fewer reagents to improve economies of testing ✔️Reliable Performance - Optically balanced primers to maximise ease-of-interpretation and reduce analysis burden ✔️Compatible with ABI 3130/3500/SeqStudio Genetic Analyser Platform - Developed for maximum compatibility with existing workflow ✔️Aligned to clinical guidelines and pathways - Meaningful results for appropriate clinical management For more information please visit our Rapid Aneuploidy Analysis page: https://hubs.la/Q02J311N0 #PCR #aneuploidy #screening #IVDs #MedicalDevices #QFPCR #NIPT #Clinical

It was wonderful to meet the Minister for Department for Science and Innovation Technology, Patrick Vallance, yesterday at our headquarters on Manchester Science Park! Dr Jo Mason, Chief Scientific Officer, was delighted to have the opportunity to speak to the Minister about Yourgene's incredible laboratory facilities and service offerings in Manchester. We held a tour of our Genomic Service laboratories that have capabilities such as DNA extraction, Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), Microarrays and NIPT screening services. We also visited our Manufacturing and Quality Control labs where we make sure our products are made to a high quality and ready for customers to use. During the visit, the team held a demonstration of our NIMBUS Select instrument, powered by Ranger Technology, which performs Next Generation DNA Size Selection for high-throughput laboratories in a variety of applications from NIPT, liquid biopsy and gene synthesis applications Huge thank you to Bruntwood SciTech for the opportunity! #ScientificCommunity #LifeSciences #Innovation #Diagnostics #ResearchService #ServiceLab

Check out our latest article published in Innovations in Pharmaceutical Technology (IPT) Summer 2024 Issue, discussing 'Next-generation size selection: accelerating the pace of gene synthesis'. Click the link to read the full article: https://lnkd.in/e2g4X2Jv #genesynthesis #DNA #syntheticbiology #geneticengineering #pharamceutical #sizeselection